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ABSTRACT 
Zika virus is a mosquito-transmitted flavivirus belongs to family Flaviviridae which becomes the focus of an ongoing pandemic and 
public health emergency all around the world. Zika virus has two lineages African and Asian. Mosquito-borne flavivirus is thought 
to replicate initially in dendritic cell and then spread to lymph nodes and then to the bloodstream. Zika virus was initially recognized 
in Uganda in 1947 in Monkeys through a method that observed yellow fever. It was later distinguished in people in 1952 in Uganda 
and the United Republic of Tanzania. The explosions of the zika virus disease have been recorded in Africa, The Americas, Asia, 
and The Pacific. Gillian-Berre syndrome and congenital malformation (microcephaly) suspected to be linked with Zika virus. The 
virus can only be confirmed through laboratory test on blood or other body fluids, such as urine, saliva or semen. No specific 
antiviral treatment for Zika virus disease exists. Treatment is aimed at relieving symptoms with rest, fluid and medications. 
WHO/PAHO encourages the countries to establish and maintain Zika Virus infections, detection, clinical management and 
community assurances strategies to reduce transmission of the virus. The future of Zika Virus spreading to other parts of the world is 
still unknown. 
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INTRODUCTION 
Zika virus is an arbovirus (arthropod-borne virus). It is a 
member of the Flaviviridae family, genus flavivirus, 
which includes dengue, yellow fever, and West Nile 
viruses. It was first identified in the zika near Kampala, 
Uganda in rhesus macaques in 1947 
1
. Zika virus is an 
icosahedral, enveloped, single-stranded positive-sense 
RNA virus with the nonsegmental genome. Virus 
structure is 40nm in diameter, with a lipid envelope 
coated with dense projections that consist of a 
membrane and enveloped glycoprotein and a dense inner 
core 2. Zika virus is a single-stranded RNA virus with 
two major lineages: Asian and Africa 
3,4
. In Africa, Zika 
virus is thought to have been largely maintained in a 
cycle involving transmission between non-human 
primates (such as monkeys and apes) and mosquitoes, 
with human as occasional unintentional hosts 
5,6
. In areas 
outside Africa, however, humans have probably become 
the main host
7
. Before November 2015 
8
 zika virus was 
a quite unknown infectious agent, generating least 
attention compared to the current year’s communicable 
disease like the MERS corona virus, influenza, and 
Ebola. The symptoms include a rash, fever, joint pain, 
red eyes, muscle pain, vomiting, and headaches. 
Management of ZIKV infected patients is easy as there 
is no zika a  specific therapeutic or vaccine available 
because of it is mild and treatable symptoms. But now 
these two factors which have to boost the Zika virus to 
an unusual position of fame. The mildness of the 
symptoms and low incidence have allowed this virus to 
slip below the attention of people 
9
. 
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Figure 1: Schematic Diagram of Zika Virus and an 
Internal component of the virus 
EPIDEMIOLOGY 
Zika virus was first isolated in April 1947 from a rhesus 
macaque monkey, which was used as a research animal 
by a scientist of the Yellow Fever Research Institute, 
located in Zika forest, near Lake Victoria Uganda. This 
scientist named this filterable transmissible agent “Zika 
Virus” in 1948 10. In January 1948, this virus was 
isolated from Aedes Africanus at the same site. The very 
first human cases were reported in 1952 in Tanzania and 
Uganda. In 2007 an outbreak caused by a strain of Asian 
lineage occurred on the ia island of Yap, an island state 
of the Federated States of Micronesia. Estimated cases 
affected in this and subsequent outbreak to date is 
probably imprecise, given the incomplete laboratory 
confirmation and similarities in clinical presentation of 
Zika virus with other arbovirus infections presents 
throughout the tropics. In Yap, 49 confirmed and 59 
probable cases (defined according to strict serological 
criteria or RNA detection by reverse transcription-
polymerase chain reaction) were defined over a four-
month period. Brazil is the most adversely affected 
country of the Latin American region with 
approximately 500,000-1,500,000 Zika Virus cases 
since March 2015 
11
. Numerous cases of the dengue-like 
syndrome in Natal, in the state of Rio Grande do Norte, 
Brazil, were confirmed as Zika Virus infection, which 
was diagnosed using reverse transcription polymerase 
chain reaction (RT-PCR). Afterward, numerous 
outbreaks occurred in the different state of Brazil, 
Colombia, Mexico, Guatemala, Paraguay, El Salvador, 
Bonaire, Samoa, Trinidad and Tobago, Aruba, Sint 
Marteen, Argentina, Venezuela, etc. and subsequently 
reached the USA. A close phylogenetic relationship 
between Asian an Oceanic strain and South America 
strains of Zika Virus may be associated with the 
introduction of Zika Virus in Brazil by the participants 
from the oceanic countries for the Va’a World Sprint 
Championship or Asian Travelers during the FIFA 
World Cup 
12,13,14,15
. 
TRANSMISSION 
In 1947, Scientist isolates the Zika virus in samples 
taken from a sentinel rhesus monkey in Zika forest, 
Uganda. The first proof of viral infection was reported 
when a researcher in Uganda who fell ill while working 
with Zika strains isolated from mosquitoes. This 
discovered that Zika virus can spread to humans. Later it 
was reported in a few African nations, the Pacific, and 
components of Asia and Yap Island, Micronesia in 
2007. In October of 2013, Zika reaches French 
Polynesia and spreading to near islands like Cook Island 
and Easter Island. The virus gradually spread to Brazil 
by May 2015 
16,17
. Zika virus continues to spread at an 
extraordinary. Currently, it is found in 14 Brazilian 
states and 10 countries in South and Central America, 
including Mexico and most recently Panama. Along 
with Dengue and Chikungunya, which are also 
transmitted by the Aedes aegypti mosquito. Zika virus is 
most likely maintained in a sylvatic cycle that includes 
non-human primates and mosquitoes with cyclic 
epizootics among monkeys in Uganda. Another 
emerging fact of the zoonosis has been the probable 
transmission through bites of monkeys and non-human 
primates. In the sylvatic transmission cycle, human 
possibly serves as incidental hosts; however, in areas 
without non-human primates, a human probably serve as 
primary intensification hosts 
18
. Zika virus was detected 
in approximately 3% of asymptomatic blood donors 
during the French Polynesian outbreak suggesting that 
transmission might be possible through infected blood 
and blood products 
19
. Evidence implies transplacental 
transmission and perinatal transmission during delivery, 
with Zika virus RNA being found in amniotic fluid and 
in paired blood samples taken from newborn infants and 
mothers 
20,21
. Unintentional sexual transmission of Zika 
virus to the female partner and subsequently to the fetus 
may result in awful congenital anomalies among the 
newborns. Transmission of Zika virus from mother to 
infant can occur in utero or perinatally 
22,23
. 
Transmission of Zika virus via breastfeeding has not yet 
been observed
 
although the transmission of another 
flavivirus via this route has been describing previously 
24,25
. The other suspected routes of Zika virus 
transmission include monkey bite, mucocutaneous 
exposure, organ transplantation or hemodialysis 
26,27,28
. 
The risk of Zika virus infection among kidney recipient 
should also be considered if the donors are either 
residing in or returning from endemic regions, because 
the virus may be shed in the urine of the infected person 
for more than 30 days 
29,30
. Due to occasional detection 
of viral RNA in a saliva sample and nasopharyngeal 
swab, it is still unknown that Zika virus could be spread 
through respiratory droplets 
31
. 
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Figure 2: All countries and regions reporting laboratory-confirmed autochthonous Zika virus. 
(http://wwwnc.cdc.gov/EID/article/22/7/15-1990-Techapp1.pdf) 
 
Figure 3: Transmission of Zika virus, Source: 
PATHOGENESIS 
Pathogenesis of Zika virus is almost unknown; however, 
it is found that mosquito-borne flaviviruses initially 
replicate in dendritic cells close to the inoculation site 
and then spread to lymph node and the blood. Although 
flaviviral replication is found to occur in cellular 
cytoplasm, studies suggest that Zika virus antigen can be 
found in the nucleus of the infected cells. Moreover, the 
infectious Zika virus has been detected in human blood 
before the beginning of symptoms. After the replication, 
zika virus may distribute from the lymphatic and 
bloodstream to infect other organs of the body such as 
the myocardium, central nervous system, skeletal 
muscles and to the fetus. The virus replication in 
astroglial cells and neurons in the brain of infected 
suckling mice results in neuronal degeneration, cellular 
infiltration, and alleviation in the brain. Furthermore, the 
evidence of inflammation is found in the myocardium 
and skeletal muscles in the infected mice. The 
neurotropism and tenacity of Zika virus may explain 
neurological complications such as microcephaly in 
congenital Zika virus infection 
32
. 
DIAGNOSIS 
Laboratory approval is necessary for the diagnosis of 
Zika infection considering that there is no 
pathognomonic presentation that differentiates Zika 
fever from other infection as well as congenital Zika 
virus infection from other etiologies of congenital 
abnormalities. There are two types of diagnosis for Zika 
infection. The first type includes the detection of the 
virus or viral particles RT-PCR, immunoassay and virus 
isolation have been invented to identify Zika virus RNA, 
viral proteins and live virus respectively. The second 
type of diagnosis is based on the detection of antibodies 
31,33
. The cross-reactivity of antibodies between 
flaviviruses confines applies to serology 
34
. 
Direct Viral Diagnosis 
Zika virus infection can be diagnosed primarily by RT-
PCR. The viremic period is believed to be small, as the 
virus can be detected in the blood from day 0 to 4 after 
the onset of symptoms. The time required for the 
recognition of viral RNA in the blood may also depend 
on the viral load during the acute phase of the disease 
because viremia decreases over time. A negative PCR 
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result in blood collected 5-7 days after the onset of 
symptoms does not exclude the flavivirus infection. 
Therefore serological testing should be considered 
35
. 
Serological Diagnosis 
Clinical signs and symptoms of Zika virus infection are 
non-specific, therefore, requiring laboratory 
examinations for differential diagnosis. Serologic test 
(i.e., enzyme-linked immunosorbent assay or 
immunofluorescence assays) is used for detection of 
ZIKV IgM antibodies from day 4 to 5 after the onset of 
symptoms. In general, the time duration for which the 
specific IgM antibodies for flavivirus remain detectable 
is 2-3 months, but sometimes for a longer period of 
time, while the specific IgG antibodies remain 
detectable for several months. At present, there is no 
validated commercial assay for Zika virus serological 
diagnosis. Therefore, serological confirmation should be 
performed in a laboratory with expertise in 
discriminating flavivirus. 
TREATMENT 
Zika virus illness is generally mild in nature, requiring 
no specific treatment. Infected patients should increase 
their fluid intake and rest for longer durations. The only 
pharmacological treatment is acetaminophen, which is 
used to alleviate a headache, fever, and myalgia. 
Pruritus can be controlled with antihistamines, while 
fluid loss through vomiting and sweating should be 
corrected with adequate rehydration. Aspirin should not 
be used because of the risk of bleeding in patients with 
thrombocytopenia and development of Reye’s syndrome 
in children under year age 
36. 
ZIKA VIRUS DRUGS 
Several research teams of scientists are in competition to 
develop a vaccine for the Zika virus 
37
. These 
researchers first screened 774 drugs and eventually limit 
them to 24 drugs that showed some potential to block 
Zika from infecting cells 
38,39,40
. An antibiotic like 
Duramycin was suggested for Zika virus, which 
decreases Zika’s ability to infect cells. The scientist will 
continue to work on vaccine development even when 
drugs that stop Zika infections are identified 
41
. 
VACCINE DELIVERY 
The Inovio ZIka product called GLS-5700 is called 
DNA vaccine. In that vaccine, DNA gets coded to yield 
the protein that encircles the Zika virus 
42
. The site of 
the injection is damaged with a device that delivers a 
short electrical pulse that guides the DNA into cells 
through a process called electroporation. The cell then 
instructs the immune system to see the Zika virus as a 
foreign invader which needs to be attacked, producing 
antibodies to fight against it 
43,44
. 
PREVENTION 
The main vectors involved in the spread and 
transmission of dengue, chikungunya, and Zika are a 
wide range of Aedes mosquitoes. Therefore, a 
preventive measure begins with strategies intended to 
avoid mosquito contact. These strategies include 
drainage of mosquito breeding site and use of 
insecticides and N, N-diethyltoluamide (DEET) or 
picaridin containing insect repellents 
45
. Regarding 
blood transfusion, testing of blood donors is suggested. 
When an outbreak happens, blood donation should be 
temporarily discontinued. In non-endemic places, using 
pre-donation questionnaire is helpful to screen donors 
who recently traveled to affected area and delay of 
blood donation from these donors until at least fourteen 
days after returning from affected places should be 
done. It is substantial to test donated organ of 
individuals who had a history of travel; to affected 
regions for Zika virus. Returned men travelers should 
persist to use condoms with a pregnant sex partner all 
over the time of pregnancy 
46
.  
CONCLUSION 
Zika virus infection is generally caused by the mosquito 
bites (Aedes aegypti and some other species), especially, 
during the daytime. It was only a mild, treatable 
infection when it was first discovered in 1948. Africa 
was considered the most affected country followed by 
South and North America which reported Zika virus 
cases. WHO and other health officials advised people to 
stay home, prevent mosquito breeding and bite, abstain 
from traveling to Zika prone or affected the region and 
abstain from sexual intercourse even if so. 
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